Cardiac gene therapy: a call for basic methods development
- PMID: 26806516
- DOI: 10.1016/S0140-6736(16)00149-5
Cardiac gene therapy: a call for basic methods development
Comment on
-
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.Lancet. 2016 Mar 19;387(10024):1178-86. doi: 10.1016/S0140-6736(16)00082-9. Epub 2016 Jan 21. Lancet. 2016. PMID: 26803443 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
